Leukemia Clinical Trials in Baltimore

Showing 861-880 of 1,908 trials

A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors

NCT03238027

A Phase 1 dose escalation study to determine if axatilimab as monotherapy and axatilimab in combination with a fixed dose of durvalumab will be sufficiently safe and well-tolerated at biologically active doses to warrant further investigation in patients with solid tumors.

Solid TumorMetastatic TumorLocally Advanced Malignant Neoplasm+1 more

Syndax Pharmaceuticals45 participantsStarted Sep 2017

Scottsdale, Arizona, United States • Baltimore, Maryland, United States • Portland, Oregon, United States +2 more locations

COMPLETEDPhase 2< 1 mile

Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.

NCT01928576

Response Rate

Non-Small Cell Lung CancerEpigenetic Therapy

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins143 participantsStarted Nov 2013

Los Angeles, California, United States • Washington D.C., District of Columbia, United States • Baltimore, Maryland, United States +2 more locations

UNKNOWNNA< 1 mile

Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures

NCT06111131

Demonstrate superiority of the Aspero Medical Ancora-SB balloon Overtube compared to the Olympus ST-SB1 Balloon Overtube.

Small Bowel Disease

Aspero Medical, Inc.123 participantsStarted Jan 2024

Los Angeles, California, United States • Baltimore, Maryland, United States • Baltimore, Maryland, United States +2 more locations

A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors

Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.

Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures

Leukemia Trials in Other Cities

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia

A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary

LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation

Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers

Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors

Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia

Dentatorubral-pallidoluysian Atrophy Natural History and Biomarkers Study

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL

A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies

A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving

An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)

A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)

Molecular Disease Characterization Initiative (MDCI)

Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies

Other Conditions in Baltimore